Population Precision Medicine in Cardiology: Bridging Health Gaps Through Integrated Risk Stratification

Introduction

The paradigm of cardiovascular medicine is undergoing a profound transformation. For decades, the cornerstone of evidence-based cardiology has been the application of findings from large randomized clinical trials to individual patients. While this “one-size-fits-all” approach has undeniably reduced cardiovascular morbidity and mortality worldwide, it inherently assumes that the “average” patient represented in clinical trials accurately reflects the individual sitting in the consultation room. In practice, clinicians continue to struggle with substantial patient variability, delayed or imprecise diagnosis of both rare and common diseases, and treatments designed for the average patient often show limited effectiveness when applied across diverse populations.

We are now entering the era of precision medicine, which promises to replace imprecise care with data-driven strategies that integrate population-level information with molecular insights. This approach aims to generate targeted treatment and care plans based on each patient’s unique clinical, genomic, and lifestyle characteristics.

[…]